Department of Medical Radiation, Islamic Azad University, Science and Research Branch, Tehran, Iran.
Department of Medicinal Chemistry, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran.
Curr Pharm Des. 2024;30(5):352-361. doi: 10.2174/0113816128284380240123071409.
Gynecologic cancers are among the most common malignancies with aggressive features and poor prognosis. Tumorigenesis in gynecologic cancers is a complicated process that is influenced by multiple factors, including genetic mutations that activate various oncogenic signaling pathways, including the TGF-β pathway. Aberrant activation of TGF-β signaling is correlated with tumor recurrence and metastasis. It has been shown that non-coding RNAs (ncRNAs) have crucial effects on cancer cell proliferation, migration, and metastasis. Upregulation of various ncRNAs, including long non-coding RNAs (lncRNA) and microRNAs (miRNAs), has been reported in several tumors, like cervical, ovarian, and endometrial cancers, but their cellular mechanisms remain to be investigated. Thus, recognizing the role of ncRNAs in regulating the TGF-β pathway may provide novel strategies for better treatment of cancer patients. The present study summarizes recent findings on the role of ncRNAs in regulating the TGF-β signaling involved in tumor progression and metastasis in gynecologic cancers.
妇科癌症是最常见的恶性肿瘤之一,具有侵袭性特征和不良预后。妇科癌症的发生是一个复杂的过程,受到多种因素的影响,包括基因突变为基础的激活各种致癌信号通路,包括 TGF-β 通路。TGF-β 信号的异常激活与肿瘤复发和转移有关。已经表明,非编码 RNA(ncRNA)对癌细胞的增殖、迁移和转移有重要影响。包括长链非编码 RNA(lncRNA)和 microRNAs(miRNAs)在内的各种 ncRNA 的上调已在几种肿瘤中报道,如宫颈癌、卵巢癌和子宫内膜癌,但它们的细胞机制仍有待研究。因此,认识到 ncRNA 在调节 TGF-β 通路中的作用可能为更好地治疗癌症患者提供新的策略。本研究总结了 ncRNA 在调节 TGF-β 信号通路在妇科癌症中的肿瘤进展和转移中的作用的最新发现。